Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China
· Delayed Price · Currency is CNY 15.17
-0.06 (-0.39%)
At close: Mar 9, 2026
Shinva Medical Instrument Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 9,203 | 10,101 | 12,036 | 8,825 | 13,087 | 5,779 | Upgrade
|
| Market Cap Growth | -7.73% | -16.07% | 36.39% | -32.57% | 126.44% | -0.42% | Upgrade
|
| Enterprise Value | 7,924 | 9,098 | 10,993 | 8,992 | 13,051 | 7,604 | Upgrade
|
| Last Close Price | 15.17 | 16.13 | 18.81 | 15.56 | 23.20 | 10.19 | Upgrade
|
| PE Ratio | 19.78 | 14.61 | 18.40 | 17.65 | 23.52 | 24.68 | Upgrade
|
| Forward PE | - | 44.46 | 44.46 | 44.46 | 44.46 | 44.46 | Upgrade
|
| PS Ratio | 0.96 | 1.01 | 1.20 | 0.95 | 1.38 | 0.63 | Upgrade
|
| PB Ratio | 1.13 | 1.26 | 1.56 | 1.53 | 2.48 | 1.19 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.47 | 1.83 | 1.90 | 3.13 | 1.61 | Upgrade
|
| P/FCF Ratio | 35.12 | 338.41 | 24.35 | 62.82 | 11.60 | 6.37 | Upgrade
|
| P/OCF Ratio | 13.02 | 22.41 | 11.68 | 22.74 | 9.33 | 5.26 | Upgrade
|
| PEG Ratio | - | 26.02 | 26.02 | 26.02 | 26.02 | 26.02 | Upgrade
|
| EV/Sales Ratio | 0.83 | 0.91 | 1.10 | 0.97 | 1.38 | 0.83 | Upgrade
|
| EV/EBITDA Ratio | 10.98 | 10.33 | 12.82 | 11.81 | 17.54 | 11.71 | Upgrade
|
| EV/EBIT Ratio | 15.25 | 13.09 | 16.40 | 15.71 | 23.00 | 16.16 | Upgrade
|
| EV/FCF Ratio | 30.24 | 304.79 | 22.24 | 64.01 | 11.57 | 8.39 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.14 | 0.21 | 0.23 | 0.46 | Upgrade
|
| Debt / EBITDA Ratio | 1.60 | 1.26 | 1.24 | 1.55 | 1.54 | 3.43 | Upgrade
|
| Debt / FCF Ratio | 4.41 | 38.06 | 2.22 | 8.49 | 1.05 | 2.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.23 | -0.28 | -0.10 | -0.09 | 0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.29 | -2.06 | -2.55 | -0.78 | -0.66 | 1.28 | Upgrade
|
| Net Debt / FCF Ratio | -6.15 | -60.63 | -4.43 | -4.25 | -0.43 | 0.92 | Upgrade
|
| Asset Turnover | 0.63 | 0.64 | 0.70 | 0.76 | 0.82 | 0.79 | Upgrade
|
| Inventory Turnover | 2.19 | 2.16 | 2.25 | 2.57 | 3.10 | 3.15 | Upgrade
|
| Quick Ratio | 0.85 | 0.79 | 0.75 | 0.58 | 0.60 | 0.55 | Upgrade
|
| Current Ratio | 1.36 | 1.29 | 1.26 | 1.07 | 1.03 | 0.96 | Upgrade
|
| Return on Equity (ROE) | 6.25% | 8.81% | 10.02% | 9.53% | 10.98% | 5.01% | Upgrade
|
| Return on Assets (ROA) | 2.13% | 2.79% | 2.94% | 2.91% | 3.06% | 2.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.87% | 10.32% | 11.45% | 10.50% | 8.39% | 5.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 8.40% | 8.30% | 9.50% | 10.10% | 8.60% | Upgrade
|
| Earnings Yield | 5.53% | 6.85% | 5.43% | 5.67% | 4.25% | 4.05% | Upgrade
|
| FCF Yield | 2.85% | 0.30% | 4.11% | 1.59% | 8.62% | 15.69% | Upgrade
|
| Dividend Yield | 1.64% | 1.55% | 2.04% | 0.74% | 0.50% | 0.75% | Upgrade
|
| Payout Ratio | 39.10% | 47.58% | 15.87% | 19.39% | 23.12% | 78.28% | Upgrade
|
| Buyback Yield / Dilution | -18.89% | -1.11% | -13.53% | -0.08% | -0.64% | 0.65% | Upgrade
|
| Total Shareholder Return | -17.25% | 0.44% | -11.48% | 0.66% | -0.14% | 1.40% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.